logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Robin E Osterhout

LinkedIn
USPTO Granted Patents = 91 

 

 

Average Co-Inventor Count = 4.1

ph-index = 10

Forward Citations = 460(Granted Patents)

Forward Citations (Not Self Cited) = 286(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal91 out of 202 
 
Genomatica, Inc.
 patents

Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Microbial Production
Carbon Flux Efficiencies
Fatty Alcohols
1,4-Butanediol
Adipate Biosynthesis
Reducing Equivalents
Methanol Utilization
Alkenes Production
Terephthalic Acid
Butadiene Biosynthesis
Gamma-Butyrolactone
Succinate Production
91 patents (USPTO):Explore Patents
1. 12435346 - Methods and organisms with increased carbon flux efficiencies (2025-10-07),
2. 12398396 - Methods for enhancing microbial production of specific length fatty alcohols in the presence of methanol (2025-08-26),
3. 12312627 - Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds (2025-05-27),
4. 12264354 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto (2025-04-01),
5. 11932893 - Microorganisms and methods for producing alkenes (2024-03-19),
6. 11932845 - Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds (2024-03-19),
7. 11834690 - Microorganisms and methods for the biosynthesis of adipate, hexamethylenediamine and 6-aminocaproic acid (2023-12-05),
8. 11814664 - Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate (2023-11-14),
9. 11753663 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam related thereto (2023-09-12),
10. 11708592 - Microorganisms and methods for the production of caprolactone (2023-07-25),
11. 11708589 - Microorganisms for producing 1,3-butanediol and methods related thereto (2023-07-25),
12. 11629363 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,2-propanediol, n-propanol, 1,3-propanediol, or glycerol related thereto (2023-04-18),
13. 11535874 - Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing succinate related thereto (2022-12-27),
14. 11447804 - Producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam in the presence of methanol using a microorganism having increased availability of reducing equivalents (2022-09-20),
15. 11401534 - Microorganisms for the production of 1,4- butanediol and related methods (2022-08-02),

Title: The Innovative Mind of Robin E Osterhout

Introduction: Robin E Osterhout is a pioneering inventor based in San Diego, CA, known for her groundbreaking contributions to various technological fields.

Latest Patents: Robin E Osterhout holds several patents in the areas of wearable technology, augmented reality devices, and biometric sensors, showcasing her commitment to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Robin E Osterhout has worked with leading tech companies to develop cutting-edge solutions that have revolutionized how we interact with technology on a daily basis.

Collaborations: Throughout her career, Robin E Osterhout has collaborated with top researchers, engineers, and designers to bring her visionary ideas to life, resulting in successful products that have garnered international acclaim.

Conclusion: Robin E Osterhout's relentless pursuit of innovation and her passion for creating transformative technologies have solidified her reputation as a trailblazer in the world of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…